US 10774083
Heterocyclic amide compound
granted A61KA61K31/437A61K31/4439
Quick answer
US patent 10774083 (Heterocyclic amide compound) held by Takeda Pharmaceutical Company Limited expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/437, A61K31/4439, A61K31/444, A61K31/501